We found that a single administration of HBK-15—a triple 5-HT1A, 5-HT7, and 5-HT3 receptor antagonist—reversed depression-like behavior and regulated decreased BDNF level in the hippocampus in mice with corticosterone-induced depression model. This evidence concerns the gene BDNF and depressive disorder.